Ferroptosis is a unique type of non-apoptotic cell death resulting from the unrestrained occurrence of peroxidized phospholipids, which are subject to iron-mediated production of lethal oxygen radicals. This cell death modality has been detected across many organisms, including in mammals, where it can be used as a defense mechanism against pathogens or even harnessed by T cells to sensitize tumor cells toward effective killing. Conversely, ferroptosis is considered one of the main cell death mechanisms promoting degenerative diseases. Emerging evidence suggests that ferroptosis represents a vulnerability in certain cancers. Here, we critically review recent advances linking ferroptosis vulnerabilities of dedifferentiating and persister cancer cells to the dependency of these cells on iron, a potential Achilles heel for small-molecule intervention. We provide a perspective on the mechanisms reliant on iron that contribute to the persister cancer cell state and how this dependency may be exploited for therapeutic benefits.
FörderungenElse Kroner-Fresenius-Stiftung Fondation Charles Defforey-Institut de France Ligue contre le Cancer Region Ile-de-France National Cancer Institute's Cancer Target Discovery and Development (CTD2) Network Deutsche Forschungsgemeinschaft (DFG) German Federal Ministry of Education and Research (BMBF) VIP+ program NEURO-PROTEKT Ministry of Science and Higher Education of The Russian Federation ERC under the European Union's Horizon 2020 research and innovation program European Research Council (ERC) under the European Union